iShares Biotechnology ETF $IBB Shares Sold by Valicenti Advisory Services Inc.

Valicenti Advisory Services Inc. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,690 shares of the financial services provider’s stock after selling 380 shares during the period. Valicenti Advisory Services Inc.’s holdings in iShares Biotechnology ETF were worth $1,858,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Destiny Wealth Partners LLC grew its holdings in iShares Biotechnology ETF by 8.5% in the 2nd quarter. Destiny Wealth Partners LLC now owns 75,784 shares of the financial services provider’s stock worth $9,587,000 after buying an additional 5,919 shares in the last quarter. CX Institutional increased its position in shares of iShares Biotechnology ETF by 984.2% during the 2nd quarter. CX Institutional now owns 2,743 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 2,490 shares during the period. Magnus Financial Group LLC lifted its holdings in shares of iShares Biotechnology ETF by 4.1% in the second quarter. Magnus Financial Group LLC now owns 10,953 shares of the financial services provider’s stock valued at $1,386,000 after buying an additional 436 shares during the period. Littlejohn Financial Services Inc. bought a new position in iShares Biotechnology ETF during the second quarter valued at about $1,463,000. Finally, Signet Financial Management LLC boosted its position in shares of iShares Biotechnology ETF by 3.3% during the 2nd quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock valued at $326,000 after purchasing an additional 83 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.4%

NASDAQ IBB opened at $140.96 on Friday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $150.04. The company’s 50 day simple moving average is $137.83 and its 200 day simple moving average is $129.56.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.